A comprehensive consolidation of data on the connection between CDKN2A polymorphisms and the susceptibility to childhood acute lymphoblastic leukemia

Background: Acute lymphoblastic leukemia is the predominant neoplastic ailment in childhood. Prior research has already established noteworthy connections between CDKN2A polymorphisms and susceptibility to this childhood leukemia, however, substantial associations are still awaiting validation. This...

Full description

Saved in:
Bibliographic Details
Main Authors: Maryam Aghasipour, Fatemeh Asadian, Seyed Alireza Dastgheib, Abolhasan Alijanpour, Ali Masoudi, Maedeh Barahman, Mohammad Golshan-Tafti, Reza Bahrami, Amirmasoud Shiri, Hossein Aarafi, Kazem Aghili, Hossein Neamatzadeh
Format: Article
Language:English
Published: Elsevier 2024-12-01
Series:Hematology, Transfusion and Cell Therapy
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2531137924028141
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850254883466248192
author Maryam Aghasipour
Fatemeh Asadian
Seyed Alireza Dastgheib
Abolhasan Alijanpour
Ali Masoudi
Maedeh Barahman
Mohammad Golshan-Tafti
Reza Bahrami
Amirmasoud Shiri
Hossein Aarafi
Kazem Aghili
Hossein Neamatzadeh
author_facet Maryam Aghasipour
Fatemeh Asadian
Seyed Alireza Dastgheib
Abolhasan Alijanpour
Ali Masoudi
Maedeh Barahman
Mohammad Golshan-Tafti
Reza Bahrami
Amirmasoud Shiri
Hossein Aarafi
Kazem Aghili
Hossein Neamatzadeh
author_sort Maryam Aghasipour
collection DOAJ
description Background: Acute lymphoblastic leukemia is the predominant neoplastic ailment in childhood. Prior research has already established noteworthy connections between CDKN2A polymorphisms and susceptibility to this childhood leukemia, however, substantial associations are still awaiting validation. This investigation was undertaken to examine the correlation between CDKN2A polymorphisms and the risk of acute lymphoblastic leukemia in children. Methods: Acquisition of information encompassed the exploration of diverse databases including PubMed, Scopus, EMBASE, and China National Knowledge Infrastructure (CNKI) until January 10, 2024. An estimation of associations was achieved utilizing odds ratios with 95% confidence intervals. Results: A total of 22 case-control studies encompassing 10,203 cases of acute lymphoblastic leukemia and 36,424 healthy controls were included. Within this pool of studies, 14 focused on rs3731217, comprising 5396 cases and 15,787 controls, whereas eight studies investigated rs3731249, comprising 4807 cases and 20,637 controls. The aggregated data showed that the rs3731217 variant offers protection against acute lymphoblastic leukemia. Nevertheless, when subgroups are analyzed according to ethnicity, it becomes clear that the rs3731217 polymorphism significantly influences susceptibility, particularly among individuals of Caucasian and African descent with no such association being observed in children of Asian origin. Nevertheless, the rs3731249 polymorphism displayed a noteworthy correlation with vulnerability to pediatric acute lymphoblastic leukemia. Conclusion: The aggregated data revealed that the rs3731217 variation offers protection against the development of pediatric acute lymphoblastic leukemia and the rs3731249 polymorphism is significantly correlated with susceptibility.
format Article
id doaj-art-8233b154e1294488bc2fee5e8d3937f0
institution OA Journals
issn 2531-1379
language English
publishDate 2024-12-01
publisher Elsevier
record_format Article
series Hematology, Transfusion and Cell Therapy
spelling doaj-art-8233b154e1294488bc2fee5e8d3937f02025-08-20T01:57:00ZengElsevierHematology, Transfusion and Cell Therapy2531-13792024-12-0146S332S34510.1016/j.htct.2024.05.017A comprehensive consolidation of data on the connection between CDKN2A polymorphisms and the susceptibility to childhood acute lymphoblastic leukemiaMaryam Aghasipour0Fatemeh Asadian1Seyed Alireza Dastgheib2Abolhasan Alijanpour3Ali Masoudi4Maedeh Barahman5Mohammad Golshan-Tafti6Reza Bahrami7Amirmasoud Shiri8Hossein Aarafi9Kazem Aghili10Hossein Neamatzadeh11College of Medicine, University of Cincinnati, Ohio, USASchool of Paramedical Science, Shiraz University of Medical Sciences, Shiraz, Iran; Corresponding author at: Department of Medical Laboratory Sciences, School of Paramedical Science, Shiraz University of Medical Sciences, Shiraz, Iran.School of Medicine, Shiraz University of Medical Sciences, Shiraz, IranBabol University of Medical Sciences, Babol, IranShahid Sadoughi University of Medical Sciences, Yazd, IranFiroozgar Hospital, Firoozgar Clinical Research Development Center (FCRDC), Iran University of Medical Sciences, Tehran, IranIslamic Azad University of Yazd, Yazd, IranNeonatal Research Center, Shiraz University of Medical Sciences, Shiraz, IranSchool of Medicine, Shahid Sadoughi University of Medical Sciences, Yazd, IranIslamic Azad University of Yazd, Yazd, IranCollege of Medicine, University of Cincinnati, Ohio, USA; School of Paramedical Science, Shiraz University of Medical Sciences, Shiraz, Iran; School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran; Babol University of Medical Sciences, Babol, Iran; Shahid Sadoughi University of Medical Sciences, Yazd, Iran; Firoozgar Hospital, Firoozgar Clinical Research Development Center (FCRDC), Iran University of Medical Sciences, Tehran, Iran; Islamic Azad University of Yazd, Yazd, Iran; Neonatal Research Center, Shiraz University of Medical Sciences, Shiraz, Iran; School of Medicine, Shahid Sadoughi University of Medical Sciences, Yazd, Iran; Shahid Rahnamoun Hospital, School of Medicine, Shahid Sadoughi University of Medical Sciences, Yazd, Iran; Mother and Newborn Health Research Center, School of Medicine, Shahid Sadoughi University of Medical Sciences, Yazd, IranMother and Newborn Health Research Center, School of Medicine, Shahid Sadoughi University of Medical Sciences, Yazd, IranBackground: Acute lymphoblastic leukemia is the predominant neoplastic ailment in childhood. Prior research has already established noteworthy connections between CDKN2A polymorphisms and susceptibility to this childhood leukemia, however, substantial associations are still awaiting validation. This investigation was undertaken to examine the correlation between CDKN2A polymorphisms and the risk of acute lymphoblastic leukemia in children. Methods: Acquisition of information encompassed the exploration of diverse databases including PubMed, Scopus, EMBASE, and China National Knowledge Infrastructure (CNKI) until January 10, 2024. An estimation of associations was achieved utilizing odds ratios with 95% confidence intervals. Results: A total of 22 case-control studies encompassing 10,203 cases of acute lymphoblastic leukemia and 36,424 healthy controls were included. Within this pool of studies, 14 focused on rs3731217, comprising 5396 cases and 15,787 controls, whereas eight studies investigated rs3731249, comprising 4807 cases and 20,637 controls. The aggregated data showed that the rs3731217 variant offers protection against acute lymphoblastic leukemia. Nevertheless, when subgroups are analyzed according to ethnicity, it becomes clear that the rs3731217 polymorphism significantly influences susceptibility, particularly among individuals of Caucasian and African descent with no such association being observed in children of Asian origin. Nevertheless, the rs3731249 polymorphism displayed a noteworthy correlation with vulnerability to pediatric acute lymphoblastic leukemia. Conclusion: The aggregated data revealed that the rs3731217 variation offers protection against the development of pediatric acute lymphoblastic leukemia and the rs3731249 polymorphism is significantly correlated with susceptibility.http://www.sciencedirect.com/science/article/pii/S2531137924028141Acute lymphoblastic leukemiaPediatricsCDKN2APolymorphism
spellingShingle Maryam Aghasipour
Fatemeh Asadian
Seyed Alireza Dastgheib
Abolhasan Alijanpour
Ali Masoudi
Maedeh Barahman
Mohammad Golshan-Tafti
Reza Bahrami
Amirmasoud Shiri
Hossein Aarafi
Kazem Aghili
Hossein Neamatzadeh
A comprehensive consolidation of data on the connection between CDKN2A polymorphisms and the susceptibility to childhood acute lymphoblastic leukemia
Hematology, Transfusion and Cell Therapy
Acute lymphoblastic leukemia
Pediatrics
CDKN2A
Polymorphism
title A comprehensive consolidation of data on the connection between CDKN2A polymorphisms and the susceptibility to childhood acute lymphoblastic leukemia
title_full A comprehensive consolidation of data on the connection between CDKN2A polymorphisms and the susceptibility to childhood acute lymphoblastic leukemia
title_fullStr A comprehensive consolidation of data on the connection between CDKN2A polymorphisms and the susceptibility to childhood acute lymphoblastic leukemia
title_full_unstemmed A comprehensive consolidation of data on the connection between CDKN2A polymorphisms and the susceptibility to childhood acute lymphoblastic leukemia
title_short A comprehensive consolidation of data on the connection between CDKN2A polymorphisms and the susceptibility to childhood acute lymphoblastic leukemia
title_sort comprehensive consolidation of data on the connection between cdkn2a polymorphisms and the susceptibility to childhood acute lymphoblastic leukemia
topic Acute lymphoblastic leukemia
Pediatrics
CDKN2A
Polymorphism
url http://www.sciencedirect.com/science/article/pii/S2531137924028141
work_keys_str_mv AT maryamaghasipour acomprehensiveconsolidationofdataontheconnectionbetweencdkn2apolymorphismsandthesusceptibilitytochildhoodacutelymphoblasticleukemia
AT fatemehasadian acomprehensiveconsolidationofdataontheconnectionbetweencdkn2apolymorphismsandthesusceptibilitytochildhoodacutelymphoblasticleukemia
AT seyedalirezadastgheib acomprehensiveconsolidationofdataontheconnectionbetweencdkn2apolymorphismsandthesusceptibilitytochildhoodacutelymphoblasticleukemia
AT abolhasanalijanpour acomprehensiveconsolidationofdataontheconnectionbetweencdkn2apolymorphismsandthesusceptibilitytochildhoodacutelymphoblasticleukemia
AT alimasoudi acomprehensiveconsolidationofdataontheconnectionbetweencdkn2apolymorphismsandthesusceptibilitytochildhoodacutelymphoblasticleukemia
AT maedehbarahman acomprehensiveconsolidationofdataontheconnectionbetweencdkn2apolymorphismsandthesusceptibilitytochildhoodacutelymphoblasticleukemia
AT mohammadgolshantafti acomprehensiveconsolidationofdataontheconnectionbetweencdkn2apolymorphismsandthesusceptibilitytochildhoodacutelymphoblasticleukemia
AT rezabahrami acomprehensiveconsolidationofdataontheconnectionbetweencdkn2apolymorphismsandthesusceptibilitytochildhoodacutelymphoblasticleukemia
AT amirmasoudshiri acomprehensiveconsolidationofdataontheconnectionbetweencdkn2apolymorphismsandthesusceptibilitytochildhoodacutelymphoblasticleukemia
AT hosseinaarafi acomprehensiveconsolidationofdataontheconnectionbetweencdkn2apolymorphismsandthesusceptibilitytochildhoodacutelymphoblasticleukemia
AT kazemaghili acomprehensiveconsolidationofdataontheconnectionbetweencdkn2apolymorphismsandthesusceptibilitytochildhoodacutelymphoblasticleukemia
AT hosseinneamatzadeh acomprehensiveconsolidationofdataontheconnectionbetweencdkn2apolymorphismsandthesusceptibilitytochildhoodacutelymphoblasticleukemia
AT maryamaghasipour comprehensiveconsolidationofdataontheconnectionbetweencdkn2apolymorphismsandthesusceptibilitytochildhoodacutelymphoblasticleukemia
AT fatemehasadian comprehensiveconsolidationofdataontheconnectionbetweencdkn2apolymorphismsandthesusceptibilitytochildhoodacutelymphoblasticleukemia
AT seyedalirezadastgheib comprehensiveconsolidationofdataontheconnectionbetweencdkn2apolymorphismsandthesusceptibilitytochildhoodacutelymphoblasticleukemia
AT abolhasanalijanpour comprehensiveconsolidationofdataontheconnectionbetweencdkn2apolymorphismsandthesusceptibilitytochildhoodacutelymphoblasticleukemia
AT alimasoudi comprehensiveconsolidationofdataontheconnectionbetweencdkn2apolymorphismsandthesusceptibilitytochildhoodacutelymphoblasticleukemia
AT maedehbarahman comprehensiveconsolidationofdataontheconnectionbetweencdkn2apolymorphismsandthesusceptibilitytochildhoodacutelymphoblasticleukemia
AT mohammadgolshantafti comprehensiveconsolidationofdataontheconnectionbetweencdkn2apolymorphismsandthesusceptibilitytochildhoodacutelymphoblasticleukemia
AT rezabahrami comprehensiveconsolidationofdataontheconnectionbetweencdkn2apolymorphismsandthesusceptibilitytochildhoodacutelymphoblasticleukemia
AT amirmasoudshiri comprehensiveconsolidationofdataontheconnectionbetweencdkn2apolymorphismsandthesusceptibilitytochildhoodacutelymphoblasticleukemia
AT hosseinaarafi comprehensiveconsolidationofdataontheconnectionbetweencdkn2apolymorphismsandthesusceptibilitytochildhoodacutelymphoblasticleukemia
AT kazemaghili comprehensiveconsolidationofdataontheconnectionbetweencdkn2apolymorphismsandthesusceptibilitytochildhoodacutelymphoblasticleukemia
AT hosseinneamatzadeh comprehensiveconsolidationofdataontheconnectionbetweencdkn2apolymorphismsandthesusceptibilitytochildhoodacutelymphoblasticleukemia